https://www.selleckchem.com/products/tak-981.html
fied with hypertension was 80.3%. CONCLUSION The findings of the current study indicate that the two-stage school and community-based screening procedure followed, effectively identified high-risk individuals and families in vulnerable populations across Europe. This approach could be potentially scalable and sustainable and support initiatives for the early prevention of T2D and hypertension. TRIAL REGISTRATION The Feel4Diabetes-intervention is registered at https//clinicaltrials.gov/ (NCT02393872; date of trial registration March 20,
Gefällt mir
Kommentar
Teilen
